• Dec 23, 2024

MicroStrategy’s Long-Shot S&P 500 Bid Stokes Wall Street Agita

(Bloomberg) -- To Michael Saylor’s online fanbase, it’s the next step in the great normalization of crypto: Bitcoin proxy MicroStrategy Inc. enters the S&P 500 next year, forcing the likes of index-tracking funds to buy his controversial company en masse. Whether they like it or not.Most Read from BloombergHo Chi Minh City Opens First Metro Line After Years of DelayReviving a Little-Known Modernist Landmark in BuffaloThe Architects Who Built MiamiNew York’s Congestion Pricing Plan Still Faces Le

  • Dec 23, 2024

Brazil Analysts See Key Rate at 15% in June, More Inflation

(Bloomberg) -- Brazil economists raised their forecasts for inflation and borrowing costs in 2025 after central bankers reinforced their commitment to extend large interest rate hikes into early next year. Most Read from BloombergHo Chi Minh City Opens First Metro Line After Years of DelayThe Architects Who Built MiamiReviving a Little-Known Modernist Landmark in BuffaloNew York’s Congestion Pricing Plan Still Faces Legal HurdlesNew York City’s Historic Preservation Movement Is Having a Midlife

  • Dec 23, 2024

Hot Obesity Drug Market Will Keep Investors Gripped Next Year

(Bloomberg) -- Disappointing trial results for Novo Nordisk A/S’s experimental obesity shot capped a volatile year for investors in drug developers vying for a piece of pharma’s hottest market.Most Read from BloombergHo Chi Minh City Opens First Metro Line After Years of DelayReviving a Little-Known Modernist Landmark in BuffaloThe Architects Who Built MiamiNew York’s Congestion Pricing Plan Still Faces Legal HurdlesNew York City’s Historic Preservation Movement Is Having a Midlife CrisisNovo sh